competition among transnational companies in the pharmaceutical industry
Clicks: 241
ID: 208953
2014
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
241 views
34 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #19 of 37 articles by views in aptechnoe delo
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Transnationals' growing importance within world economy has become an extremely controversial topic. Appreciated by some, disapproved by others, these giant firms are certainly reality in nowadays economy and they are the most important economic agents all over the world. Companies of this kind have reached so much expansion that they have somehow lost their national feature. For these firms competition is no longer national, but
international, against foreign companies with the same profile, to cover large segments of the global market.
Transnationals are fundamental in competition's globalization. Transnational manufacturing has inserted the global competition within national markets, so that many firms are forced to manufacture at the international border of efficiency or get out of business. Transnationals have developed over the last decades, as they have worked on their competitive advantages at international level. These advantages emerge from scale
economies, higher management techniques and/or world sales networks. The rapid changes brought about by globalization generate new huge opportunities for those able to find the
answers that suit the new conditions, but also imply new risks to those who cannot adapt.
| Reference Key |
voiculet2014studiacompetition
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Alina Voiculet |
| Journal | aptechnoe delo |
| Year | 2014 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.